Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Serum Separation Gel Market Size & Growth Forecast 2027–2036, By Segments (Product, Source), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14794| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Serum Separation Gel Market size was worth USD 8.84 billion in 2026 and is expected to grow at a 6.3% CAGR between 2027 and 2036, surpassing USD 16.28 billion by 2036. The industry revenue for 2027 is calculated at USD 9.37 billion.

Base Year Value (2026)
USD 8.84 billion
CAGR (2027-2036)
6.3%
Forecast Year Value (2036)
USD 16.28 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Serum Separation Gel Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads through mature clinical diagnostics infrastructure, high routine blood testing volumes, established laboratory workflows, and broad adoption of advanced blood collection systems across healthcare facilities.
  • Asia Pacific is expected to grow at a 7.91% CAGR, driven by expanding diagnostic testing, greater healthcare access, rising laboratory capacity, and increasing emphasis on reliable high-throughput specimen processing.

Segment Momentum

  • They lead due to streamlined workflow efficiency, combining collection and separation in one system, improving sample consistency and reducing handling steps, making them preferred in high-throughput diagnostic laboratory environments.
  • Pharmaceutical companies are the fastest-growing source due to expanding R&D needs requiring controlled, reproducible sample preparation and consistent separation performance across drug development and clinical testing workflows.

Market Expansion Drivers

  • Expanding blood bank infrastructure increasing demand for serum collection and diagnostic testing.
  • Rising bloodstream infection prevalence accelerating infectious disease diagnostic test volumes.
  • Growing laboratory automation investments improving adoption of advanced specimen processing consumables.

Leading Market Participants

  • Leading companies in the serum separation gel market include Becton, Dickinson and Company (United States), Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (United States), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (United States), Agilent Technologies, Inc. (United States), Thermo Fisher Scientific Inc. (United States).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 8.84 billion
  • 2027 Estimated Market Size: USD 9.37 billion.
  • Projected Market Size: USD 16.28 billion by 2036
  • Growth Forecast: 6.3% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Serum Separation Gel With Integrated Tubes (Product) | Blood Banks (Source)
  • Emerging Opportunity Segment: Serum Separation Gel With Integrated Tubes (Product) | Pharmaceutical Companies (Source)
Market Dynamics

Market Growth Drivers and Industry Trends

Expanding blood bank infrastructure increasing demand for serum collection and diagnostic testing

Expansion of blood bank infrastructure across healthcare systems will drive the serum separation gel market growth by increasing the volume and frequency of blood sample collection, processing, and diagnostic testing. As blood banks expand their collection capacity and strengthen specimen-handling workflows, laboratories require reliable consumables that can support efficient separation of serum from blood components while maintaining sample integrity. Serum separation gels help create a physical barrier between serum and cellular components during centrifugation, reducing the risk of contamination and supporting consistent specimen preparation. Greater availability of organized blood collection facilities also increases demand for standardized sample-processing practices across hospitals, diagnostic centers, and blood banks, encouraging wider use of serum separation tubes and related consumables.

Rising bloodstream infection prevalence accelerating infectious disease diagnostic test volumes

The growing incidence of bloodstream infections is increasing the need for timely laboratory diagnosis, and this trend will propel the serum separation gel market growth as healthcare providers process more patient specimens for infectious disease evaluation. Bloodstream infections often require laboratory testing to identify underlying infections and guide appropriate clinical management, creating sustained demand for dependable blood collection and serum preparation procedures. Serum separation gels facilitate efficient specimen handling by supporting the clear separation of serum from blood cells, which can improve laboratory workflow and reduce unnecessary sample manipulation. Rising attention to early detection, infection monitoring, and diagnostic testing in hospitals further contributes to higher utilization of serum-based laboratory consumables.

Growing laboratory automation investments improving adoption of advanced specimen processing consumables

Investment in laboratory automation is encouraging diagnostic facilities to adopt consumables that can integrate smoothly with standardized and high-throughput specimen workflows, supporting growth of the serum separation gel market. Automated laboratories increasingly prioritize consistent sample preparation, reduced manual intervention, and efficient movement of specimens across collection, centrifugation, and analysis stages. Separation gels can support these requirements by providing a standardized approach to serum isolation and helping laboratories maintain uniform specimen quality during automated processing. As diagnostic laboratories modernize their infrastructure and expand automated testing capabilities, demand for compatible specimen-processing consumables is strengthened by the need to improve operational efficiency and minimize variability in routine sample handling.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising demand for serum separation in diagnostics 2.20% Short term (≤ 2 yrs) North America, Europe Medium Fast
Advancements in gel and tube technologies 2.40% Medium term (2–5 yrs) North America, Asia Pacific Low Moderate
Expansion of clinical labs in emerging markets 2.40% Long term (5+ yrs) Asia Pacific, Latin America Low Slow
Expanding blood bank infrastructure increasing demand for serum collection and diagnostic testing 2.00% Moderate North America, Asia Pacific, Europe High Near Term
Rising bloodstream infection prevalence accelerating infectious disease diagnostic test volumes 1.80% High North America, Europe High Near Term
Growing laboratory automation investments improving adoption of advanced specimen processing consumables 1.30% Moderate Asia Pacific, Latin America Medium Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Serum Separation Gel Market
Largest Region
North America
XX% Market Share in 2026

North America (Largest Region)

In the serum separation gel market, North America held the largest share in 2026, supported by advanced clinical laboratory infrastructure, high adoption of automated diagnostic workflows, and strong demand for reliable specimen-processing technologies. Serum separation gels are widely used to facilitate efficient blood sample handling and improve the consistency of laboratory testing, making them well suited to the region's sophisticated healthcare environment. Growing diagnostic testing volumes, expansion of outpatient laboratory services, and increasing emphasis on efficient sample preparation are supporting demand. Continued laboratory automation and quality-focused practices further reinforce the region's established position.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, increasing access to clinical diagnostics, and rising demand for efficient laboratory testing across developing healthcare systems. Improvements in hospital and diagnostic laboratory capabilities are encouraging the adoption of standardized specimen collection and separation technologies. Growing awareness of laboratory quality, increasing healthcare expenditure, and broader availability of automated diagnostic equipment are creating favorable conditions for serum separation gel adoption. The expansion of preventive healthcare and diagnostic screening is also strengthening demand for dependable sample-processing solutions.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Diagnostic Material Quality

Germany emphasizes premium serum separation gel materials that support precise clinical diagnostics and laboratory efficiency. Suppliers are focusing on product consistency, regulatory compliance, and compatibility with automated blood collection systems.

France 🇫🇷

Clinical Testing Reliability

France continues to adopt serum separation gel products that improve sample preservation across hospital and diagnostic laboratory networks. Market activity centers on dependable specimen quality and compatibility with evolving laboratory testing requirements.

Italy 🇮🇹

Hospital Laboratory Efficiency

Italy is strengthening serum separation gel utilization as healthcare laboratories optimize blood collection and diagnostic workflows. Suppliers are focusing on dependable separation performance and product quality to support routine clinical testing across healthcare facilities.

Japan 🇯🇵

Precision Sample Processing

Japan advances serum separation gel adoption by prioritizing reliable specimen handling in high-throughput diagnostic laboratories. Healthcare providers seek gel formulations that preserve sample quality while supporting increasingly automated laboratory operations.

South Korea 🇰🇷

Laboratory Innovation Support

South Korea is expanding the use of serum separation gel products alongside investments in advanced clinical laboratory infrastructure. Manufacturers are introducing improved gel technologies that enhance sample separation efficiency and analytical reliability.

United States 🇺🇸

High-Volume Laboratory Supply

The U.S. maintains strong demand for serum separation gel products as laboratories expand automated blood collection and diagnostic testing capacity. Manufacturers are developing formulations that improve specimen stability and compatibility with modern laboratory workflows.

Segment Analysis

Segment Leadership and Growth Trends

Serum Separation Gel Market Share (%), by Product, 2026

Serum Separation Gel With Integrated Tubes
Serum Separation Gel Without Integrated Tubes

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Serum Separation Gel With Integrated Tubes (Largest & Fastest-Growing Segment)

Serum separation gel with integrated tubes represented the largest share of the serum separation gel market in 2026 while also emerging as the fastest-growing product segment. The integrated configuration streamlines specimen collection and serum separation by combining key components into a convenient format, reducing handling requirements and supporting efficient laboratory workflows. Its ability to improve sample processing consistency, simplify preparation, and minimize opportunities for handling-related errors makes it attractive across diagnostic and clinical testing environments.

Source Segment Analysis: Blood Banks (Largest Segment) vs Pharmaceutical Companies (Fastest-Growing Segment)

Blood banks accounted for the largest share of the serum separation gel market in 2026, reflecting their significant requirement for efficient blood sample processing and reliable separation procedures. Serum separation products support organized specimen handling and help facilitate downstream laboratory analysis, making them valuable within workflows involving large volumes of collected samples. The need for consistent sample quality and streamlined processing further strengthens the position of blood banks as an important source segment.

Pharmaceutical companies are expected to record the fastest growth as expanding research, development, and analytical activities increase the need for dependable serum sample preparation. Serum separation gels can support laboratory workflows associated with biomarker analysis, clinical research, and other pharmaceutical testing activities by simplifying specimen processing. The growing emphasis on efficient sample handling and reproducible laboratory procedures is expected to encourage wider adoption within pharmaceutical research environments.

Segment Sub-Segment Largest Segment Fastest Growing
Product Serum Separation Gel Without Integrated Tubes, Serum Separation Gel With Integrated Tubes Serum Separation Gel With Integrated Tubes Serum Separation Gel With Integrated Tubes
Source Blood Banks, Hospitals, Pharmaceutical Companies, Others Blood Banks Pharmaceutical Companies
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the serum separation gel market:

1. Becton Dickinson and Company (United States)

2. Abbott Laboratories (United States)

3. F. Hoffmann-La Roche Ltd (Switzerland)

4. Siemens Healthineers AG (Germany)

5. Danaher Corporation (United States)

6. QIAGEN N.V. (Netherlands)

7. Bio-Rad Laboratories Inc. (United States)

8. Agilent Technologies Inc. (United States)

9. Thermo Fisher Scientific Inc. (United States)

The serum separation gel market is experiencing steady innovation in sample processing efficiency and laboratory accuracy. Improved gel formulations are enhancing stability and separation performance in diagnostic workflows. Continuous R&D efforts are driving material refinement for better compatibility. Collaborative development activities are further supporting product consistency, strengthening the serum separation gel market in clinical and research applications.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Becton Dickinson and Company (United States)
Abbott Laboratories (United States)
F. Hoffmann-La Roche Ltd (Switzerland)
Siemens Healthineers AG (Germany)
Danaher Corporation (United States)
QIAGEN N.V. (Netherlands)
Bio-Rad Laboratories Inc. (United States)
Agilent Technologies Inc. (United States)
Thermo Fisher Scientific Inc. (United States).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Serum Separation Gel Market — Custom Segments

Segment Sub-Segment
Clinical Application Clinical Chemistry, Immunoassay and Serology, Molecular Diagnostics, Therapeutic Drug Monitoring
Distribution Channel Direct Sales, Medical Distributors, Online Sales
Purchase Model Direct Procurement, Distributor-Based Procurement, Group Purchasing Organization (GPO) Procurement

Serum Separation Gel Market — Custom TOC

Custom Chapter Custom Details
Clinical Laboratory Workflow Optimization
  • Pre-Analytical Workflow and Sample Processing Requirements
  • Serum Separation Performance and Laboratory Efficiency
  • Workflow Bottlenecks and Operational Improvement Opportunities
  • Automation Compatibility and Laboratory Technology Integration
  • Productivity and Quality Enhancement Priorities
Diagnostic Laboratory Demand and Adoption Opportunities
  • Emerging Diagnostic Testing Trends Driving Demand
  • Laboratory Adoption Across Hospital and Independent Settings
  • Application-Specific Requirements and Usage Patterns
  • Adoption Barriers and Switching Considerations
  • High-Potential Demand Opportunities
Supplier and Raw Material Risk Management
  • Critical Raw Material Requirements and Supply Dependencies
  • Supplier Ecosystem and Sourcing Concentration
  • Supply Disruption Exposure and Operational Vulnerabilities
  • Quality, Consistency, and Qualification Considerations
  • Supply Resilience and Risk Mitigation Priorities

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the market valuation of serum separation gel?

The market size of serum separation gel in 2027 is calculated to be USD 9.37 billion.

What are the growth projections for the serum separation gel industry?

Serum Separation Gel Market size was worth USD 8.84 billion in 2026 and is expected to grow at a 6.3% CAGR between 2027 and 2036, surpassing USD 16.28 billion by 2036.

How are integrated serum separation gel tubes influencing efficiency in high-throughput diagnostic laboratories?

Integrated tube formats streamline sample collection and separation into a single step, reducing handling complexity and improving consistency. This supports higher throughput and more standardized workflows in diagnostic laboratories where efficiency and sample integrity are critical.

What role is automation playing in shifting purchasing behavior toward advanced serum separation gel consumables?

Laboratory automation is increasing demand for consumables that integrate smoothly with high-throughput systems. Serum separation gel products are preferred because they improve separation consistency, reduce manual intervention, and align with automated workflows focused on turnaround time and operational efficiency.

Why do Serum Separation Gel With Integrated Tubes dominate this market?

They lead due to streamlined workflow efficiency, combining collection and separation in one system, improving sample consistency and reducing handling steps, making them preferred in high-throughput diagnostic laboratory environments.

Why is demand rising for serum separation gels among pharmaceutical companies?

Pharmaceutical companies are the fastest-growing source due to expanding R&D needs requiring controlled, reproducible sample preparation and consistent separation performance across drug development and clinical testing workflows.

What makes North America the largest regional market for serum separation gel?

North America leads through mature clinical diagnostics infrastructure, high routine blood testing volumes, established laboratory workflows, and broad adoption of advanced blood collection systems across healthcare facilities.

Why is Asia Pacific emerging as the fastest-growing serum separation gel market?

Asia Pacific is expected to grow at a 7.91% CAGR, driven by expanding diagnostic testing, greater healthcare access, rising laboratory capacity, and increasing emphasis on reliable high-throughput specimen processing.

Which companies dominate the serum separation gel landscape?

Leading companies in the serum separation gel market include Becton, Dickinson and Company (United States), Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (United States), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (United States), Agilent Technologies, Inc. (United States), Thermo Fisher Scientific Inc. (United States).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →